Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 08/26 10:01:35 pm
23.97 USD   +0.84%
08/24 BOSTON SCIENTIF : To Participate In Wells Fargo 2016 Healthcare Conf..
08/17 BOSTON SCIENTIF : FDA Approves Boston Scientific’s MR System
08/11 BOSTON SCIENTIF : Sci Wins FDA Approval for MRI-Safe S-ICD
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
24.12(c) 24.11(c) 23.63(c) 23.77(c) 23.97(c) Last
3 185 465 4 339 079 4 882 285 7 808 986 6 738 041 Volume
-0.21% -0.04% -1.99% +0.59% +0.84% Change
More quotes
Financials ($)
Sales 2016 8 312 M
EBIT 2016 1 756 M
Net income 2016 595 M
Debt 2016 4 054 M
Yield 2016 -
Sales 2017 8 764 M
EBIT 2017 2 054 M
Net income 2017 1 457 M
Debt 2017 2 542 M
Yield 2017 -
P/E ratio 2016 49,25
P/E ratio 2017 24,73
EV / Sales2016 4,41x
EV / Sales2017 4,01x
Capitalization 32 617 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in a broad range of interventional medical specialties.The company's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive,... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
08/25 BOSTON SCIENTIFIC : Patent Issued for Method for Treating Prolapse and Incontine..
08/24 BOSTON SCIENTIFIC : To Participate In Wells Fargo 2016 Healthcare Conference
08/18 BOSTON SCIENTIFIC : Announces U.S. FDA Approval Of EMBLEM MRI S-ICD System
08/17 BOSTON SCIENTIFIC : FDA Approves Boston Scientific’s MR System
08/17 BOSTON SCIENTIFIC : Combine Solicitation - 65-- BRAND NAME BOSTON SCIENTIFIC STE..
08/11 BOSTON SCIENTIFIC : Sci Wins FDA Approval for MRI-Safe S-ICD
08/10 BOSTON SCIENTIFIC : Sources Sought Notice - Boston Scientific Cardiac Supplies
08/09 BOSTON SCIENTIFIC : $32,045 Federal Contract Awarded to Boston Scientific
08/09 BOSTON SCIENTIFIC : Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD Syste..
08/09 BOSTON SCIENTIFIC : Announces U.S. FDA Approval Of EMBLEM(TM) MRI S-ICD System
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
News from SeekingAlpha
08/01 BEST AND WORST Q3'16 : Health Care ETFs, Mutual Funds And Key Holdings
07/28 Boston Scientific (BSX) Michael F. Mahoney on Q2 2016 Results - Earnings Call..
07/28 Boston Scientific Q2 top line up 15%; non-GAAP net income up 28%; shares up 4..
07/28 Boston Scientific EPS in-line, beats on revenue
07/27 Notable earnings before Thursday?s open
Advertisement
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 27,3 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..29.99%32 617
THERMO FISHER SCIENTIF..7.41%60 070
PHILIPS10.29%27 591
INTUITIVE SURGICAL, IN..25.47%26 379
ILLUMINA, INC.-10.28%25 246
EDWARDS LIFESCIENCES C..45.94%24 536
More Results